Lipase inhibitor

This page covers all Lipase inhibitor drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Pancreatic lipase, gastric lipase, Pancreatic lipase.

Targets

Pancreatic lipase, gastric lipase · Pancreatic lipase

Marketed (1)

• Orlistat (Xenical) · St. Louis University · Obesity/Weight management
  Orlistat inhibits pancreatic and gastric lipases to reduce the absorption of dietary fats in the gastrointestinal tract.

Phase 2 pipeline (1)

• Conventional orlistat 120 mg, · Empros Pharma AB · Obesity
  Inhibits pancreatic lipase to reduce fat absorption